CINECA IRIS Institutional Research Information System

CONVERTINO, IRMA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.021
EU - Europa 1.260
AS - Asia 684
AF - Africa 180
OC - Oceania 25
SA - Sud America 24
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.198
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.993
IT - Italia 466
SE - Svezia 305
CN - Cina 177
SG - Singapore 176
GB - Regno Unito 133
BG - Bulgaria 122
IN - India 92
CI - Costa d'Avorio 89
DE - Germania 83
VN - Vietnam 63
SN - Senegal 54
TR - Turchia 51
FI - Finlandia 43
NG - Nigeria 32
HK - Hong Kong 31
FR - Francia 30
CA - Canada 25
AU - Australia 24
JP - Giappone 24
ID - Indonesia 19
AT - Austria 15
KR - Corea 14
IR - Iran 12
CO - Colombia 11
PT - Portogallo 11
ES - Italia 10
BR - Brasile 7
PL - Polonia 6
CL - Cile 5
MY - Malesia 5
NL - Olanda 5
UA - Ucraina 5
CH - Svizzera 4
EU - Europa 4
RU - Federazione Russa 4
CZ - Repubblica Ceca 3
EG - Egitto 3
GR - Grecia 3
IE - Irlanda 3
IQ - Iraq 3
MX - Messico 3
PK - Pakistan 3
TW - Taiwan 3
IL - Israele 2
JO - Giordania 2
PH - Filippine 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AR - Argentina 1
BJ - Benin 1
EE - Estonia 1
ET - Etiopia 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 4.198
Salva come PNG Salva come JPEG
Città #
Chandler 213
Fairfield 184
Ashburn 172
Sofia 122
Singapore 116
Florence 110
Woodbridge 100
Abidjan 89
Santa Clara 88
Boardman 87
New York 87
Ann Arbor 86
Houston 86
London 78
Wilmington 72
Princeton 71
Milan 63
Cambridge 55
Dakar 54
Seattle 54
Lawrence 53
Serra 46
Istanbul 45
Medford 44
Lagos 32
Pisa 31
Helsinki 30
Beijing 28
Hong Kong 28
Redwood City 28
Kent 27
Dong Ket 25
Rome 25
Bremen 24
Mumbai 19
Los Angeles 18
Hyderabad 17
Shanghai 17
Munich 15
San Diego 15
Washington 15
Fuzhou 14
Vienna 14
Ogden 13
Ho Chi Minh City 12
Jakarta 12
Ottawa 12
Modugno 11
Dallas 10
Norwalk 10
Chicago 9
Mountain View 9
Marseille 8
Melbourne 8
Nanjing 8
Quanzhou 8
San Francisco 8
Naples 7
Birmingham 6
Dearborn 6
Des Moines 6
Jeju City 6
Sydney 6
Tokyo 6
Toronto 6
Turin 6
Duncan 5
Lappeenranta 5
New Malden 5
Redmond 5
Rio de Janeiro 5
Santiago 5
Santiago de Cali 5
Torres Vedras 5
Xiamen 5
Cascina 4
Chennai 4
Esslingen am Neckar 4
Livorno 4
Madrid 4
Palermo 4
Pomona 4
Porto Azzurro 4
Scarlino 4
Warsaw 4
Bengaluru 3
Bomba 3
Cairo 3
Cepagatti 3
Chions 3
Dalian 3
Denver 3
Edgware 3
Guarda 3
Jamshedpur 3
Kariya 3
Kuala Lumpur 3
Lancaster 3
Lisbon 3
Malang 3
Totale 2.920
Salva come PNG Salva come JPEG
Nome #
Expected and actual adverse drug-drug interactions in elderly patients accessing the emergency department: data from the ANCESTRAL-ED study 159
Allopurinol adherence among patients with gout: an Italian general practice database study 125
Potential Direct Costs of Adverse Drug Events and Possible Cost Savings Achievable by their Prevention in Tuscany, Italy: A Model-Based Analysis 109
The Anti-TNF Drugs and the Risk of Lymphoma, Skin Cancer and Melanoma: A Signal Detection Analysis 107
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 105
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 97
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 92
Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database 90
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study 89
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 89
QT Interval Prolongation and Hydroxyzine: A Retrospective Cohort Analysis on Hospitalized Elderly Patients 88
Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis 87
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 87
Antibiotic Drugs and Unresolved Sensory Side Effects: Analysis of Eudravigilance Database of Suspected Adverse Drug Reaction Reports 87
Diabetes drugs and the incidence of solid cancers: a survey of the current evidence 85
The usefulness of listening social media for pharmacovigilance purposes: a systematic review 85
Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy) 84
Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies 81
Listening Social Media for Pharmacovigilance Objectives: Which Usefulness? 80
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database 77
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 77
Adverse drug reactions in oncoLogy: intEnsive monitoring program on biotechnological anD taRget therapies in Oncologic patientS-ALEXANDROS observational study 76
IntenSive Monitoring Program of TeratOgen and Non-Teratogen Risk of Drugs During Pregnancy: the STORK Project 75
Raynaud’s Phenomenon Associated with Calcitonin Gene-Related Peptide (CGRP) Antagonists: a Disproportionality Analysis on VigiBase 74
Anticoagulant Therapy and Risk of Bleeding in Patients with Atrial Fibrillation of Four Italian Regions: The TYRION Study 73
Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy 72
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 70
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) 69
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline 67
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients 66
Unresolved gustatory, olfactory and auditory adverse drug reactions to antibiotic drugs: a survey of spontaneous reporting to Eudravigilance 65
A clinician network for sharing patients experiences in pharmacovigilance: the PHARMACOWIKILANCE project 62
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) 62
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 60
Potential and Actual Drug-Drug Interactions in Elderly Patients Admitted to an Emergency Department: Data from the ANCESTRAL-ED Study 59
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future 58
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 58
Anti-tumor Necrosis Factor Drugs and Risk of Lymphoma in Patients with Inflammatory Bowel Disease 57
A Model-Based Analysis on Direct Costs of Adverse Drug Events and Related Cost-Savings Achievable by their Prevention in Tuscany, Italy 57
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study 57
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance 56
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES 55
Anticoagulant Therapy in Patients with Atrial Fibrillation and Risk of Bleeding: Interim Analysis: Tyrion Study 54
Bleeding Related to Oral Anticoagulant Drugs as Cause of Emergency Department Admission: Analysis of Data from the Tuscan MEREAFaPS Network 54
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 53
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs 53
Disproportionality Analysis of ‘‘Early-Onset’’ Tardive Dyskinesia Stratified by Time to Onset Using FAERS Database. 50
Characterization of the Risk of Bleeding with Novel Oral Anticoagulants and Warfarin: A Pilot Case-Control Study 50
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 49
Challenges of Pharmacovigilance in the Neonate 49
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project 48
Update of Certolizumab Pegol Safety Profile: A Systematic Review and Meta-Analysis 46
Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments 43
Estimation of Theoretical Cost Preventability Achievable with an Effective Pharmacovigilance Activity in a Pharmacovigilance Regional Centre in Italy 42
Muscular adverse drug reactions associated with proton pump inhibitors: a disproportionality analysis using the Italian National Network of Pharmacovigilance database 41
Fatal Fat Overload Syndrome Following Intravenous Lipid Emulsion Administration as Antidote in Suspected Anesthetic Intoxication: A Fatal Medication Error. 34
Severe Cardiac Events Following Treatment with Trastuzumab in Women with Breast Cancer: A Meta-Analysis of Clinical Trials and Cohort Studies 34
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis 24
Analysis of the Drug Related Emergency Department Admissions in Tuscany: The FARO Project 23
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 20
A regulatory overview of biosimilars across selected countries 20
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 19
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option 19
Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients 18
Oral Presentation: Signal of Hypertension Associated with COVID-19 Vaccination: VigiBase (R) Data and Evidence from Real World 18
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence 16
Supporting the Spontaneous Reporting by Health Care Professionals of the University Hospital of Pisa, Italy: a Pilot Project from the Unit of Adverse Drug Reactions Monitoring 16
Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use 14
Assessment of Healthcare Facilities Associated with JAKi Drugs Used in Rheumatoid Arthritis Patients in Tuscany, Italy: The LEONARDO 13
Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study 13
Erratum to: Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System (Drug Safety, (2023), 46, 3, (283-295), 10.1007/s40264-022-01269-x) 13
Unresolved Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Signal Detection Analysis on Publicly Accessible Eudravigilance Data 11
Oral Presentation: Accesses to Emergency Department and Hospitalizations in New Users of Biologic Therapies for Ulcerative Colitis in Tuscany: The MICHELANGELO Study 11
COVID-19 Vaccines and Thromboembolic Events with Thrombocytopenia: Data from Italian Pharmacovigilance Public Database 11
Fat overload syndrome following intravenous lipid emulsion administration as antidote in suspected anesthetic intoxication: insights from a clinical and forensic case experience 9
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison 9
Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall 8
Risk of Hospitalization Associated with Cardiovascular Medications in the Elderly Italian Population: A Nationwide Multicenter Study in Emergency Departments 7
Drug Safety and Relevant Issues in the Real-World 5
Authors’ response: Inhibiting IL-6 in COVID-19: we are not sure that sgp130(fc) can affect only the trans-signaling receptor pathway of IL-6 5
A Cross-National Comparison of Biosimilars Pricing in Argentina, Australia, Brazil, and Italy 5
Communicating Drug Safety 5
Real-world evidence and pharmacovigilance: workshop of the Italian Epidemiological Association and of the Italian Society of Pharmacology 3
Totale 4.363
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.543
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020271 0 0 0 0 30 37 47 36 35 19 52 15
2020/2021290 13 13 4 12 16 2 10 7 24 10 20 159
2021/2022825 12 31 79 89 124 111 34 48 48 22 55 172
2022/20231.112 148 205 78 65 88 98 32 53 230 2 109 4
2023/2024927 34 53 64 32 102 149 100 60 39 46 119 129
2024/2025608 43 116 114 216 119 0 0 0 0 0 0 0
Totale 4.363